Search Results - "Nunez, Kelley G"

Lineage-specific regulation of PD-1 expression in early-stage hepatocellular carcinoma following 90yttrium transarterial radioembolization - Implications in treatment outcomes by Núñez, Kelley G, Sandow, Tyler, Gimenez, Juan, Hibino, Mina, Fort, Daniel, Cohen, Ari J, Thevenot, Paul T

“…Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related deaths in the world. Liver-directed therapies, including Yttrium ( Y)…”
Get full text

Assessment of Response to Transcatheter Arterial Chemoembolization with Doxorubicin-eluting Microspheres: Tumor Biology and Hepatocellular Carcinoma Recurrence in a 5-year Transplant Cohort by Sandow, Tyler A, Arndt, Stephen E, Albar, Abeer A, DeVun, Daniel A, Kirsch, David S, Gimenez, Juan M, Bohorquez, Humberto E, Gilbert, Patrick J, Thevenot, Paul T, Nunez, Kelley G, Galliano, Gretchen A, Cohen, Ari J, Kay, Dennis, Gulotta, Paul M

“…Purpose To assess response to transcatheter arterial chemoembolization (TACE) based on immune markers and tumor biology in patients with hepatocellular…”
Get full text

PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survival by Núñez, Kelley G., Sandow, Tyler, Fort, Daniel, Hibino, Mina, Wright, Paige, Cohen, Ari J., Thevenot, Paul T.

“…Background Hepatocellular carcinoma (HCC) patients undergo liver-directed therapy (LDT) to control tumor burden while awaiting liver transplantation with…”
Get full text

Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular Carcinoma by Stanneart, Jordin, Nunez, Kelley G, Sandow, Tyler, Gimenez, Juan, Fort, Daniel, Hibino, Mina, Cohen, Ari J, Thevenot, Paul T

“…Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related deaths in the world. Patients with early-stage HCC are treated with…”
Get full text

Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant Candidates by Núñez, Kelley G, Sandow, Tyler, Patel, Jai, Hibino, Mina, Fort, Daniel, Cohen, Ari J, Thevenot, Paul

“…Due to active hepatocellular carcinoma (HCC) surveillance, many patients are diagnosed with early-stage disease and are usually amendable to curative…”
Get full text

Interleukin-33 / Cyclin D1 imbalance in severe liver steatosis predicts susceptibility to ischemia reperfusion injury by Núñez, Kelley G, Frank, Anderson, Gonzalez-Rosario, Janet, Galliano, Gretchen, Bridle, Kim, Crawford, Darrell, Seal, John, Abbruscato, Frank, Vashistha, Himanshu, Thevenot, Paul T, Cohen, Ari J

“…Transplanting donor livers with severe macrosteatosis is associated with increased risk of primary non-function (PNF). The purpose of this study was to…”
Get full text

Distinct Gene Expression Profiles in Viable Hepatocellular Carcinoma Treated With Liver-Directed Therapy by Núñez, Kelley G., Sandow, Tyler, Lakey, Meredith A., Fort, Daniel, Cohen, Ari J., Thevenot, Paul T.

“…Background Hepatocellular carcinoma is a heterogeneous tumor that accumulates a mutational burden and dysregulated signaling pathways that differ from early to…”
Get full text

Exosome Shedding Is Concordant with Objective Treatment Response Rate and Stratifies Time to Progression in Treatment Naïve, Non-Resectable Hepatocellular Carcinoma by Núñez, Kelley G., Wyczechowska, Dorota, Hibino, Mina, Sandow, Tyler, Gimenez, Juan, Koksal, Ali R., Aydin, Yucel, Dash, Srikanta, Cohen, Ari J., Thevenot, Paul T.

“…Translational strategies to characterize and monitor extracellular vesicles such as exosome (EX) shedding and the clinical impact of this data within…”
Get full text

Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma by Núñez, Kelley G., Sandow, Tyler, Fort, Daniel, Patel, Jai, Hibino, Mina, Carmody, Ian, Cohen, Ari J., Thevenot, Paul

“…The biomarkers α-fetoprotein (AFP), Lens culinaris agglutinin-reactive AFP fraction (AFP-L3), and des-γ-carboxy prothrombin (DCP) have emerging implications in…”
Get full text

Cyclin D1 in the Liver: Role of Noncanonical Signaling in Liver Steatosis and Hormone Regulation by Núñez, Kelley G, Gonzalez-Rosario, Janet, Thevenot, Paul T, Cohen, Ari J

“…Cyclin D1 is an important protein for cell cycle progression; however, functions independent of the cell cycle have been described in the liver. Cyclin D1 is…”
Get full text

Enhanced venous thrombosis and hypercoagulability in murine and human metabolic dysfunction-associated steatohepatitis by Pandey, Nilesh, Anand, Sumit Kumar, Kaur, Harpreet, Richard, Koral S.E., Chandaluri, Lakshmi, Butler, Megan E., Zhang, Xiaolu, Pearson-Gallion, Brenna, Rohilla, Sumati, Das, Sandeep, Magdy, Tarek, Sethu, Palaniappan, Núñez, Kelley G., Orr, A. Wayne, Stokes, Karen Y., Thevenot, Paul T., Cohen, Ari J., Rom, Oren, Dhanesha, Nirav

“…Patients with metabolic dysfunction-associated steatohepatitis (MASH) are at an increased risk of developing venous thromboembolic events, including deep vein…”
Get full text

P171 Donor specific antibody in simultaneous liver-kidney transplantation: preformed class II HLA antibodies and acute renal and hepatic allograft rejection by Robertson, Sarah E., Núñez, Kelley G., Cherry, Jamie, Cooper, E. Shannon, Alquist, Caroline R.

Get full text